Addex Therapeutics Ltd (ADXN) Stock Forecast
ADXN analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $30.00 average of analyst targets
- Upside to target
- +987.0% from the latest close
- Next earnings
- December 3, 2026
- 52-week range
- $2.65 – $9.92
ADXN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ADXN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | — | — | — |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ADXN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $1.5M | $1.5M | $1.5M | 0.0% | 1 |
ADXN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ADXN revenue: reported and forecast
ADXN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ADXN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ADXN beat in 2 of 7.
What analysts expect from ADXN
The average price target is $30.00, 987.0% above the latest close of $2.76. For 2026 the average estimate is $0.00 per share on revenue of $1.5 million. Addex Therapeutics beat the EPS estimate in 2 of the last 7 quarters.
Related: ADXN income statement, ADXN key metrics, ADXN chart. See the ADXN stock overview for the latest quote and news.
ADXN forecast FAQ
What is Addex Therapeutics's price target?
The average analyst price target for Addex Therapeutics is $30.00, 987.0% above the latest close of $2.76.
When does Addex Therapeutics report earnings?
Addex Therapeutics is expected to report results for the quarter ending September 30, 2026 on December 3, 2026.
Does Addex Therapeutics usually beat earnings estimates?
Addex Therapeutics reported EPS at or above the analyst estimate in 2 of the last 7 quarters.